Consumers ripped off by a Cincinnati sex-drug company will share in $24 million that former top officials were forced to turn over to the government. The U.S. Department of Justice already has approved payments to 138,426 people identified as victims of Berkeley Premium Nutraceuticals Inc., which in the early 2000s sold male-enhancement drugs such as Enzyte and female sexual-dysfunction drugs such as Avlimil.